228 related articles for article (PubMed ID: 11991754)
1. E1B-55K-deleted adenovirus expressing E1A-13S by AFP-enhancer/promoter is capable of highly specific replication in AFP-producing hepatocellular carcinoma and eradication of established tumor.
Takahashi M; Sato T; Sagawa T; Lu Y; Sato Y; Iyama S; Yamada Y; Fukaura J; Takahashi S; Miyanishi K; Yamashita T; Sasaki K; Kogawa K; Hamada H; Kato J; Niitsu Y
Mol Ther; 2002 May; 5(5 Pt 1):627-34. PubMed ID: 11991754
[TBL] [Abstract][Full Text] [Related]
2. A hepatocellular carcinoma-specific adenovirus variant, CV890, eliminates distant human liver tumors in combination with doxorubicin.
Li Y; Yu DC; Chen Y; Amin P; Zhang H; Nguyen N; Henderson DR
Cancer Res; 2001 Sep; 61(17):6428-36. PubMed ID: 11522637
[TBL] [Abstract][Full Text] [Related]
3. Target gene therapy for alpha-fetoprotein-producing hepatocellular carcinoma by E1B55k-attenuated adenovirus.
Ohashi M; Kanai F; Tateishi K; Taniguchi H; Marignani PA; Yoshida Y; Shiratori Y; Hamada H; Omata M
Biochem Biophys Res Commun; 2001 Mar; 282(2):529-35. PubMed ID: 11401492
[TBL] [Abstract][Full Text] [Related]
4. Complete eradication of hepatomas using an oncolytic adenovirus containing AFP promoter controlling E1A and an E1B deletion to drive IL-24 expression.
Zhang KJ; Zhang J; Wu YM; Qian J; Liu XJ; Yan LC; Zhou XM; Xiao RJ; Wang YG; Cao X; Wei N; Liu XR; Tang B; Jiao XY; Chen K; Liu XY
Cancer Gene Ther; 2012 Sep; 19(9):619-29. PubMed ID: 22790965
[TBL] [Abstract][Full Text] [Related]
5. Prolonged survival of mice with multiple liver metastases of human colon cancer by intravenous administration of replicable E1B-55K-deleted adenovirus with E1A expressed by CEA promoter.
Sagawa T; Takahashi M; Sato T; Sato Y; Lu Y; Sumiyoshi T; Yamada Y; Iyama S; Fukaura J; Sasaki K; Hamada H; Miyanishi K; Takayama T; Kato J; Niitsu Y
Mol Ther; 2004 Dec; 10(6):1043-50. PubMed ID: 15564136
[TBL] [Abstract][Full Text] [Related]
6. A novel tumor-specific replication-restricted adenoviral vector for gene therapy of hepatocellular carcinoma.
Hallenbeck PL; Chang YN; Hay C; Golightly D; Stewart D; Lin J; Phipps S; Chiang YL
Hum Gene Ther; 1999 Jul; 10(10):1721-33. PubMed ID: 10428217
[TBL] [Abstract][Full Text] [Related]
7. Treatment of hepatocellular carcinoma by AdAFPep/rep, AdAFPep/p53, and 5-fluorouracil in mice.
Sagawa T; Yamada Y; Takahashi M; Sato Y; Kobune M; Takimoto R; Fukaura J; Iyama S; Sato T; Miyanishi K; Matsunaga T; Takayama T; Kato J; Sasaki K; Hamada H; Niitsu Y
Hepatology; 2008 Sep; 48(3):828-40. PubMed ID: 18756484
[TBL] [Abstract][Full Text] [Related]
8. A tumor-specific conditionally replicative adenovirus vector expressing TRAIL for gene therapy of hepatocellular carcinoma.
Ren XW; Liang M; Meng X; Ye X; Ma H; Zhao Y; Guo J; Cai N; Chen HZ; Ye SL; Hu F
Cancer Gene Ther; 2006 Feb; 13(2):159-68. PubMed ID: 16082383
[TBL] [Abstract][Full Text] [Related]
9. Conditionally replicative adenovirus vector carrying TRAIL gene for enhanced oncolysis of human hepatocellular carcinoma.
Ye X; Lu Q; Zhao Y; Ren Z; Ren XW; Qiu QH; Tong Y; Liang M; Hu F; Chen HZ
Int J Mol Med; 2005 Dec; 16(6):1179-84. PubMed ID: 16273304
[TBL] [Abstract][Full Text] [Related]
10. Retrovirus-mediated gene therapy for hepatocellular carcinoma: selective and enhanced suicide gene expression regulated by human alpha-fetoprotein enhancer directly linked to its promoter.
Mawatari F; Tsuruta S; Ido A; Ueki T; Nakao K; Kato Y; Tamaoki T; Ishii N; Nakata K
Cancer Gene Ther; 1998; 5(5):301-6. PubMed ID: 9824049
[TBL] [Abstract][Full Text] [Related]
11. E1A, E1B double-restricted replicative adenovirus at low dose greatly augments tumor-specific suicide gene therapy for gallbladder cancer.
Fukuda K; Abei M; Ugai H; Kawashima R; Seo E; Wakayama M; Murata T; Endo S; Hamada H; Hyodo I; Yokoyama KK
Cancer Gene Ther; 2009 Feb; 16(2):126-36. PubMed ID: 18818710
[TBL] [Abstract][Full Text] [Related]
12. Gene therapy for alpha-fetoprotein-producing human hepatoma cells by adenovirus-mediated transfer of the herpes simplex virus thymidine kinase gene.
Kanai F; Shiratori Y; Yoshida Y; Wakimoto H; Hamada H; Kanegae Y; Saito I; Nakabayashi H; Tamaoki T; Tanaka T; Lan KH; Kato N; Shiina S; Omata M
Hepatology; 1996 Jun; 23(6):1359-68. PubMed ID: 8675152
[TBL] [Abstract][Full Text] [Related]
13. Development of a gene therapy strategy to target hepatocellular carcinoma based inhibition of protein phosphatase 2A using the α-fetoprotein promoter enhancer and pgk promoter: an in vitro and in vivo study.
Li W; Li DM; Chen K; Chen Z; Zong Y; Yin H; Xu ZK; Zhu Y; Gong FR; Tao M
BMC Cancer; 2012 Nov; 12():547. PubMed ID: 23173703
[TBL] [Abstract][Full Text] [Related]
14. Genetically modified adenoviruses against gliomas: from bench to bedside.
Gomez-Manzano C; Yung WK; Alemany R; Fueyo J
Neurology; 2004 Aug; 63(3):418-26. PubMed ID: 15304571
[TBL] [Abstract][Full Text] [Related]
15. Augmenting the antitumor effect of TRAIL by SOCS3 with double-regulated replicating oncolytic adenovirus in hepatocellular carcinoma.
Wei RC; Cao X; Gui JH; Zhou XM; Zhong D; Yan QL; Huang WD; Qian QJ; Zhao FL; Liu XY
Hum Gene Ther; 2011 Sep; 22(9):1109-19. PubMed ID: 21361790
[TBL] [Abstract][Full Text] [Related]
16. Cancer targeting Gene-Viro-Therapy of liver carcinoma by dual-regulated oncolytic adenovirus armed with TRAIL gene.
Cao X; Yang M; Wei RC; Zeng Y; Gu JF; Huang WD; Yang DQ; Li HL; Ding M; Wei N; Zhang KJ; Xu B; Liu XR; Qian QJ; Liu XY
Gene Ther; 2011 Aug; 18(8):765-77. PubMed ID: 21412282
[TBL] [Abstract][Full Text] [Related]
17. Insulation from viral transcriptional regulatory elements enables improvement to hepatoma-specific gene expression from adenovirus vectors.
Ye X; Liang M; Meng X; Ren X; Chen H; Li ZY; Ni S; Lieber A; Hu F
Biochem Biophys Res Commun; 2003 Aug; 307(4):759-64. PubMed ID: 12878174
[TBL] [Abstract][Full Text] [Related]
18. Gene therapy targeting for hepatocellular carcinoma: selective and enhanced suicide gene expression regulated by a hypoxia-inducible enhancer linked to a human alpha-fetoprotein promoter.
Ido A; Uto H; Moriuchi A; Nagata K; Onaga Y; Onaga M; Hori T; Hirono S; Hayashi K; Tamaoki T; Tsubouchi H
Cancer Res; 2001 Apr; 61(7):3016-21. PubMed ID: 11306481
[TBL] [Abstract][Full Text] [Related]
19. Dissecting the roles of E1A and E1B in adenoviral replication and RCAd-enhanced RDAd transduction efficacy on tumor cells.
Wei F; Wang H; Chen X; Li C; Huang Q
Cancer Biol Ther; 2014 Oct; 15(10):1358-66. PubMed ID: 25019940
[TBL] [Abstract][Full Text] [Related]
20. Highly augmented cytopathic effect of a fiber-mutant E1B-defective adenovirus for gene therapy of gliomas.
Shinoura N; Yoshida Y; Tsunoda R; Ohashi M; Zhang W; Asai A; Kirino T; Hamada H
Cancer Res; 1999 Jul; 59(14):3411-6. PubMed ID: 10416603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
